VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
ATPC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
ATPCAgape ATP Corporation
$2.97$3M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksATPCFinancials

Agape ATP Corporation (ATPC) Financials

11Y historyFree accessUpdated daily

The company struggles with extreme negative operating leverage, evidenced by an operating margin of -2.5% in 2026Q1 despite maintaining a gross margin of 57.7%.

ATPC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Jun'19Jun'18Jun'17Jun'16
Sales/Revenue1.51M1.52M1.32M1.43M1.86M1.02M3.45M858.72K1.55M487K00
Revenue Growth %16.68%15.23%-7.57%-22.92%82.56%-70.55%302.06%-44.46%217.46%---
Cost of Goods Sold689.15K706.18K563.6K494.52K666.04K297.33K775.86K766.96K1.44M441.41K00
COGS % of Revenue-46.33%42.61%34.56%35.88%29.24%22.47%89.31%92.93%90.64%--
Gross Profit819.73K818.08K759.15K936.57K1.19M719.63K2.68M91.77K109.35K45.6K00
Gross Margin %54.33%53.67%57.39%65.44%64.13%70.76%77.53%10.69%7.07%9.36%--
Gross Profit Growth %-7.76%-18.94%-21.33%65.44%-73.12%2816.95%-16.08%139.83%---
Operating Expenses4.03M4.07M3.33M3.08M2.72M2.58M2.83M624.54K607.36K276.47K75.36K300K
OpEx % of Revenue-267.32%251.94%215.44%146.71%253.52%82.11%72.73%39.28%56.77%--
Selling, General & Admin3.57M3.54M3.33M3.08M2.72M2.46M2.83M624.54K607.36K265.68K75.36K300K
SG&A % of Revenue-232.05%251.94%215.44%146.71%241.57%82.11%72.73%39.28%54.55%--
Research & Development000000000000
R&D % of Revenue------------
Other Operating Expenses464.76K537.65K000121.51K000-14K00
Operating Income-3.21M-3.26M-2.57M-2.15M-1.53M-1.86M-158.13K-532.77K-514.51K-366.96K-75.36K-300K
Operating Margin %-212.98%-213.65%-194.55%-150%-82.59%-182.76%-4.58%-62.04%-33.28%-75.35%--
Operating Income Growth %--26.55%-19.88%-40%17.5%-1075.3%70.32%-3.55%-40.21%-386.94%74.88%-
EBITDA-2.99M-3.03M-2.35M-1.92M-1.32M-1.64M5.34K-677.87K-353.37K-132.88K00
EBITDA Margin %-198.06%-198.7%-177.41%-134.4%-70.85%-161.4%0.15%-78.94%-22.86%-27.28%--
EBITDA Growth %-27.75%-29.06%-22.01%-46.23%19.86%-30848.58%100.79%-91.83%-165.94%---
D&A (Non-Cash Add-back)225.05K227.98K226.65K223.19K217.94K217.21K163.47K0161.14K234.09K75.36K300K
EBIT-3.21M-3.26M-2.57M-2.15M-1.53M-1.86M-158.13K-677.87K-131.17K-234.09K00
Net Interest Income1533.42K67.93K29.25K16.19K25.57K000000
Interest Income1533.42K67.93K29.25K16.19K25.57K000000
Interest Expense000000000000
Other Income/Expense1.28M951.33K92.23K40.22K-136.87K-529.04K674.48K-145.09K-5.13K109.15K00
Pretax Income-1.93M-2.31M-2.48M-2.11M-1.67M-2.39M516.35K-677.86K-519.64K-124.94K-75.36K-300K
Pretax Margin %-128.13%-151.24%-187.57%-147.19%-89.96%-234.78%14.96%-78.94%-33.61%-25.65%--
Income Tax2.29K2.29K4.93K3.58K-4.05K137.07K161.58K005.33K00
Effective Tax Rate %-0.12%-0.1%-0.2%-0.17%0.24%-5.74%31.29%0%0%-4.27%0%0%
Net Income-1.91M-2.28M-2.47M-2.1M-1.69M-2.52M354.77K-677.86K-519.64K-130.27K-75.36K-300K
Net Margin %-126.48%-149.57%-186.77%-146.88%-90.86%-248.21%10.28%-78.94%-33.61%-26.75%--
Net Income Growth %22.41%7.72%-17.53%-24.61%33.17%-811.52%152.34%-30.45%-298.88%-72.86%74.88%-
Net Income (Continuing)-1.94M-2.31M-2.49M-2.11M-1.67M-2.52M354.77K-677.86K-519.64K-130.27K-75.36K-300K
Discontinued Operations000000000000
Minority Interest-46.74K-33.45K-3.79K11.78K20.51K-336000000
EPS (Diluted)-1.91-2.85-31.50-1.39-0.96-0.340.05-0.09-0.07-0.02-0.01-0.04
EPS Growth %92.57%90.95%-2174.37%-44.27%-186.57%-844.44%150%-28.57%-366.67%-50%75%-
EPS (Basic)--2.85-31.50-1.39-0.96-0.340.05-0.09-0.07-0.02-0.01-0.04
Diluted Shares Outstanding1M801.08K1.27M1.52M1.76M7.52M7.53M7.53M7.53M7.53M7.53M7.53M
Basic Shares Outstanding1M801.08K1.27M1.52M1.76M7.52M7.53M7.53M7.53M7.47M7.53M7.53M
Dividend Payout Ratio------------

Key Metrics

Growth RegimeMixed
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Severe liquidity and solvency

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Inconsistent Revenue Growth Patterns

According to the provided quarterly data, ATPC's revenue trajectory remains highly volatile, with recent figures showing a 10.9% increase in 2025Q4 followed by a 5.3% contraction in 2026Q1, highlighting the difficulty in sustaining consistent top-line expansion within the competitive Malaysian health supplement market.

The lack of a clear growth trend suggests that the company's advisory-led model may struggle with customer retention or cyclical demand shifts. Investors should monitor whether the fluctuations in revenue are tied to specific product launches or if they reflect a broader instability in the underlying member base.

Gross Margin Resilience Amid Losses

As reported in financial statements, ATPC maintains a gross margin profile averaging above 50%, with a 53.6% reading in 2025Q4, which suggests that the company's premium wellness products retain significant pricing power despite the firm's inability to achieve operational profitability at the current scale.

While the gross margin indicates a successful premium positioning, the wide variance in quarterly margins—ranging from 44.9% to 64.5%—implies potential volatility in input costs or promotional discounting. This inconsistency warrants further investigation into whether the company can maintain these margins as it attempts to scale its distribution network.

Operating Leverage Remains Deeply Negative

Based on the income statement data, ATPC exhibits extreme negative operating leverage, as evidenced by an operating margin of -213.65% in recent periods, indicating that the company's fixed administrative and SG&A costs are vastly outsized relative to its current revenue-generating capacity.

The data suggests that the corporate infrastructure is currently too heavy for the business's small revenue base, creating a structural misalignment that prevents profitability. Without a significant reduction in overhead or a massive surge in sales volume, the company appears unlikely to achieve positive operating income in the near term.

SG&A Burden Outstrips Revenue

Analysis of the income statement reveals that SG&A expenses consistently dwarf gross profits, with 2025Q4 SG&A reaching $1.1M against a gross profit of only $213.8K, demonstrating a lack of expense discipline that continues to drive significant quarterly net losses.

The persistent reliance on high SG&A spending suggests that the company may be aggressively funding customer acquisition or administrative overhead that is not yielding a commensurate return. This cost structure appears unsustainable and may necessitate a fundamental pivot in how the company manages its operational footprint.

Liquidity Risks Threaten Operational Continuity

Financial disclosures indicate a precarious liquidity position, with cash reserves of only $140,072 against a recurring quarterly net loss profile, suggesting that the company may face a significant funding gap that could force dilutive financing or threaten its ability to continue as a going concern.

The disconnect between the company's growth ambitions and its limited cash runway is a primary concern for investors. The current burn rate suggests that the company's survival may depend on its ability to secure external capital, which remains uncertain given the lack of a clear path to profitability.

ATPC — Frequently Asked Questions

Quick answers to the most common questions about buying ATPC stock.

What was Agape ATP Corporation's (ATPC) revenue in 2025?

For fiscal year 2025, Agape ATP Corporation (ATPC) reported total revenue of $1.5M.

Is Agape ATP Corporation (ATPC) profitable?

Agape ATP Corporation (ATPC) reported a net loss of $2.3M for the fiscal year ending 2025.

What is Agape ATP Corporation's operating profit margin?

Agape ATP Corporation (ATPC) reported an operating income of $-3.3M, resulting in an operating profit margin of -213.7%. This margin reflects the operational efficiency of the business before interest and taxes.

What is Agape ATP Corporation's gross profit and gross margin?

Agape ATP Corporation (ATPC) generated $0.8M in gross profit for the year, representing a gross profit margin of 53.7%. This demonstrates the company's core pricing power and production efficiency.